ProfileGDS4132 / 1563312_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 39% 32% 41% 41% 33% 34% 37% 37% 35% 40% 29% 32% 31% 32% 32% 25% 30% 31% 28% 28% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10199.574239
GSM201543Muscle PCOS pioglitazone 12170.742332
GSM201544Muscle PCOS pioglitazone 161108.84941
GSM201545Muscle PCOS pioglitazone 201113.50741
GSM201829Muscle PCOS pioglitazone 23186.861833
GSM201830Muscle PCOS pioglitazon 25189.55534
GSM201831Muscle PCOS pioglitazone 27194.517337
GSM201832Muscle PCOS pioglitazone 3194.741837
GSM201833Muscle PCOS pioglitazone 4182.170935
GSM201834Muscle PCOS pioglitazone 81102.08340
GSM201835Muscle PCOS after pioglitazone 10257.951129
GSM201836Muscle PCOS after pioglitazone 12267.980632
GSM201837Muscle PCOS after pioglitazone 16262.817631
GSM201838Muscle PCOS after pioglitazone 20270.741832
GSM201839Muscle PCOS after pioglitazone 23273.842332
GSM201840Muscle PCOS after pioglitazone 25257.364725
GSM201841Muscle PCOS after pioglitazone 27259.311330
GSM201842Muscle PCOS after pioglitazone 3260.466931
GSM201843Muscle PCOS after pioglitazone 4267.479128
GSM201844Muscle PCOS after pioglitazone 8262.78828